tiprankstipranks
Trending News
More News >
Artivion Inc. (AORT)
:AORT
US Market
Advertisement

Artivion (AORT) Earnings Dates, Call Summary & Reports

Compare
372 Followers

Earnings Data

Report Date
Feb 12, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.06
Last Year’s EPS
-0.39
Same Quarter Last Year
Based on 7 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter with significant revenue and EBITDA growth driven by key product lines. Positive clinical data and reimbursement updates further strengthen the company's position. However, challenges include costs related to a past cybersecurity incident and expected growth rate challenges for AMDS in 2026.
Company Guidance
In the third quarter of 2025, Artivion reported robust financial performance characterized by a 16% year-over-year growth in total constant currency revenue and a 39% increase in adjusted EBITDA. Key contributors to this growth included significant gains in their stent graft product line, which saw a 31% revenue increase, and the On-X heart valve business, which grew by 23%. The company also highlighted the favorable impact of new clinical data and reimbursement updates on their AMDS technology, anticipating further market expansion opportunities, particularly in the U.S., estimated at an annual $150 million market potential. Gross margins improved to 65.6%, up from 63.7% in the previous year, driven by favorable product mix including AMDS HDE revenues in the U.S. and strong On-X growth. For the full year 2025, Artivion raised its revenue guidance to $439 million to $445 million and adjusted EBITDA guidance to reflect a 24% to 28% increase over 2024, with expectations of maintaining double-digit revenue growth into 2026.
Strong Revenue and EBITDA Growth
Total constant currency revenue growth of 16% and adjusted EBITDA growth of 39% year-over-year, reflecting strong financial performance.
Stent Graft and On-X Valves as Growth Drivers
Stent graft revenues grew 31% and On-X valve revenues grew 23% year-over-year on a constant currency basis, acting as significant growth engines for the company.
New Clinical Data and Reimbursement Updates
Positive clinical data presented at EX for AMDS and establishment of the approved DRG-209 reimbursement code, enhancing the value proposition for AMDS.
Expansion into New Facilities
Entered into two real estate agreements to expand On-X operational footprint in Austin, Texas, to support future growth.
Pipeline and Market Opportunities
Robust pipeline expected to unlock approximately $1 billion of incremental market opportunity over the next 5-plus years.

Artivion (AORT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AORT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 12, 2026
2025 (Q4)
0.06 / -
-0.39
Nov 06, 2025
2025 (Q3)
0.02 / 0.13
-0.05360.00% (+0.18)
Aug 07, 2025
2025 (Q2)
>-0.01 / 0.03
-0.05160.00% (+0.08)
May 05, 2025
2025 (Q1)
-0.12 / -0.01
0.18-105.56% (-0.19)
Feb 24, 2025
2024 (Q4)
-0.07 / -0.39
-0.1-290.00% (-0.29)
Nov 07, 2024
2024 (Q3)
-0.06 / -0.05
-0.2479.17% (+0.19)
Aug 08, 2024
2024 (Q2)
-0.09 / -0.05
-0.0837.50% (+0.03)
May 06, 2024
2024 (Q1)
-0.12 / 0.18
-0.33154.55% (+0.51)
Feb 15, 2024
2023 (Q4)
-0.09 / -0.10
0.05-300.00% (-0.15)
Nov 02, 2023
2023 (Q3)
-0.06 / -0.24
-0.3429.41% (+0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AORT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$47.50$44.87-5.54%
Aug 07, 2025
$32.70$40.95+25.23%
May 05, 2025
$23.77$27.42+15.36%
Feb 24, 2025
$27.85$25.56-8.22%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Artivion Inc. (AORT) report earnings?
Artivion Inc. (AORT) is schdueled to report earning on Feb 12, 2026, After Close (Confirmed).
    What is Artivion Inc. (AORT) earnings time?
    Artivion Inc. (AORT) earnings time is at Feb 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AORT EPS forecast?
          AORT EPS forecast for the fiscal quarter 2025 (Q4) is 0.06.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis